Announcements

25 November 2024
Biomedicines | Hot Papers in the “Endocrinology and Metabolism Research” Section

The “Endocrinology and Metabolism Research” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of endocrinology and metabolism. Papers aimed at uncovering the molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include, but are not limited to, gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism etc.), and metabolic diseases. In this context, we are pleased to feature some recently published papers on endocrinology and metabolism in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.

1. “The Role of Adipokines in Health and Disease”
by Vicente Javier Clemente-Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, Alexandra Martín-Rodríguez, Ismael Martínez-Guardado, Eduardo Navarro-Jiménez, Carmen Cecilia Laborde-Cárdenas and José Francisco Tornero-Aguilera
Biomedicines 2023, 11(5), 1290; https://doi.org/10.3390/biomedicines11051290
Available online: https://www.mdpi.com/2227-9059/11/5/1290

2. “Estrogens in Adipose Tissue Physiology and Obesity-Related Dysfunction”
by Alina Kuryłowicz
Biomedicines 2023, 11(3), 690; https://doi.org/10.3390/biomedicines11030690
Available online: https://www.mdpi.com/2227-9059/11/3/690

3. “Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma”
by Marcin Kosmalski, Agnieszka Śliwińska and Józef Drzewoski
Biomedicines 2023, 11(4), 1097; https://doi.org/10.3390/biomedicines11041097
Available online: https://www.mdpi.com/2227-9059/11/4/1097

4. “Adipokines as Clinically Relevant Therapeutic Targets in Obesity”
by Marleen Würfel, Matthias Blüher, Michael Stumvoll, Thomas Ebert, Peter Kovacs, Anke Tönjes and Jana Breitfeld
Biomedicines 2023, 11(5), 1427; https://doi.org/10.3390/biomedicines11051427
Available online: https://www.mdpi.com/2227-9059/11/5/1427

5. “Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome”
by Aleksandra Maria Kicińska, Radoslaw B. Maksym, Magdalena A. Zabielska-Kaczorowska, Aneta Stachowska and Anna Babińska
Biomedicines 2023, 11(6), 1567; https://doi.org/10.3390/biomedicines11061567
Available online: https://www.mdpi.com/2227-9059/11/6/1567

6. “Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review”
by Fnu Deepika, Siresha Bathina and Reina Armamento-Villareal
Biomedicines 2023, 11(2), 644; https://doi.org/10.3390/biomedicines11020644
Available online: https://www.mdpi.com/2227-9059/11/2/644

7. “Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update”
by Rosaria Vincenza Giglio, Angelo Maria Patti, Ali Abbas Rizvi, Anca Panta Stoian, Marcello Ciaccio, Nikolaos Papanas, Andrej Janez, Alper Sonmez, Maciej Banach, Amirhossein Sahebkar et al.
Biomedicines 2023, 11(2), 291; https://doi.org/10.3390/biomedicines11020291
Available online: https://www.mdpi.com/2227-9059/11/2/291

8. “Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes”
by Angelo Maria Patti, Rosaria Vincenza Giglio, Alberto Allotta, Andreina Bruno, Tommaso Di Bella, Anca Pantea Stoian, Marcello Ciaccio and Manfredi Rizzo
Biomedicines 2023, 11(5), 1362; https://doi.org/10.3390/biomedicines11051362
Available online: https://www.mdpi.com/2227-9059/11/5/1362

9. “Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact”
by Wesal Elgretli, Tianyan Chen, Nadine Kronfli and Giada Sebastiani
Biomedicines 2023, 11(2), 271; https://doi.org/10.3390/biomedicines11020271
Available online: https://www.mdpi.com/2227-9059/11/2/271

10. “Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19”
by Thomas Grewal and Christa Buechler
Biomedicines 2023, 11(5), 1302; https://doi.org/10.3390/biomedicines11051302
Available online: https://www.mdpi.com/2227-9059/11/5/1302

We would like to take this opportunity to thank all the research groups that have submitted their papers to Biomedicines. We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.

Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).

Biomedicines Editorial Office

25 November 2024
Biomedicines | Hot Papers in the “Drug Discovery, Development and Delivery” Section

The Section “Drug Discovery, Development and Delivery” publishes original and innovative scientific papers, as well as comprehensive review papers. It is organized into topics mainly covering drug discovery, drug design, basic and clinical pharmacology, formulation and delivery, and toxicology.

1. “Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterpenes, Carnosic Acid and Carnosol”
by Solomon Habtemariam
Biomedicines 2023, 11(2), 545; https://doi.org/10.3390/biomedicines11020545
Available online: https://www.mdpi.com/2227-9059/11/2/545

2. “G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy”
by Bárbara Bahls , Israa M. Aljnadi, Rita Emídio, Eduarda Mendes and Alexandra Paulo
Biomedicines 2023, 11(3), 969; https://doi.org/10.3390/biomedicines11030969
Available online: https://www.mdpi.com/2227-9059/11/3/969

3. “Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps”
by María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, Delia Dávila-Quintana, Carlos Cabrera-López, Teresa Carrillo-Díaz and Jesús Javier Benítez del Rosario
Biomedicines 2023, 11(2), 485; https://doi.org/10.3390/biomedicines11020485
Available online: https://www.mdpi.com/2227-9059/11/2/485

4. “Biological Fluid Microsampling for Therapeutic Drug Monitoring: A Narrative Review”
by Alessia Cafaro, Matteo Conti, Federica Pigliasco, Sebastiano Barco, Roberto Bandettini and Giuliana Cangemi
Biomedicines 2023, 11(7), 1962; https://doi.org/10.3390/biomedicines11071962
Available online: https://www.mdpi.com/2227-9059/11/7/1962

5. “Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes”
by Hugo Luiz, Jacinta Oliveira Pinho and Maria Manuela Gaspar
Biomedicines 2023, 11(2), 435; https://doi.org/10.3390/biomedicines11020435
Available online: https://www.mdpi.com/2227-9059/11/2/435

6. “Glutathione: Lights and Shadows in Cancer Patients”
by Herbert Ryan Marini, Bianca Arianna Facchini, Raffaele di Francia, José Freni, Domenico Puzzolo, Liliana Montella, Gaetano Facchini, Alessandro Ottaiano, Massimiliano Berretta and Letteria Minutoli
Biomedicines 2023, 11(8), 2226; https://doi.org/10.3390/biomedicines11082226
Available online: https://www.mdpi.com/2227-9059/11/8/2226

7. “Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review”
by Roland Gál, Róbert Halmosi, Ferenc Gallyas, Jr., Michael Tschida, Pornthira Mutirangura, Kálmán Tóth, Tamás Alexy and László Czopf
Biomedicines 2023, 11(11), 2888; https://doi.org/10.3390/biomedicines11112888
Available online: https://www.mdpi.com/2227-9059/11/11/2888

8. “Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates”
by Seetharamsing Balamkundu and Chuan-Fa Liu
Biomedicines 2023, 11(11), 3080; https://doi.org/10.3390/biomedicines11113080
Available online: https://www.mdpi.com/2227-9059/11/11/3080

9. “Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents”
by Erika Plazas and Nicoletta Faraone
Biomedicines 2023, 11(2), 461; https://doi.org/10.3390/biomedicines11020461
Available online: https://www.mdpi.com/2227-9059/11/2/461

10. “Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review”
by Jung Yoon Jang, Donghwan Kim and Nam Deuk Kim
Biomedicines 2023, 11(6), 1635; https://doi.org/10.3390/biomedicines11061635
Available online: https://www.mdpi.com/2227-9059/11/6/1635

We would like to take this opportunity to thank all the research groups that have submitted to Biomedicines (ISSN: 2227-9059). We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.

Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).

Biomedicines Editorial Office

25 November 2024
Biomedicines | Hot Papers in the “Immunology and Immunotherapy” Section

The “Immunology and Immunotherapy” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and onco-immunology. The papers aim to uncover and provide insights into the modulations of the immune system, active and passive immunotherapies, the diagnostic tests based on specific markers, and the use of new technologies to identify novel predictive factors that respond to immunotherapy. Topics include, but are not limited to, in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; the use of nanoparticles and microvesicles for developing immunotherapeutics; etc. In this context, we are pleased to feature some recently published papers on immunology and immunotherapy in Biomedicines (ISSN: 2227-9059), which provide valuable information on this exciting field.

1. “Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy”
by Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar and Piu Saha
Biomedicines 2023, 11(2), 294; https://doi.org/10.3390/biomedicines11020294
Available online: https://www.mdpi.com/2227-9059/11/2/294

2. “Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice”
by Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia et al.
Biomedicines 2023, 11(4), 1071; https://doi.org/10.3390/biomedicines11041071
Available online: https://www.mdpi.com/2227-9059/11/4/1071

3. “The Influence of Gut Microbiota on Oxidative Stress and the Immune System”
by Claudia Kunst, Stephan Schmid, Marlen Michalski, Deniz Tümen, Jonas Buttenschön, Martina Müller and Karsten Gülow
Biomedicines 2023, 11(5), 1388; https://doi.org/10.3390/biomedicines11051388
Available online: https://www.mdpi.com/2227-9059/11/5/1388

4. “Fecal Microbiota Transplantation in Inflammatory Bowel Disease”
by Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Paula Anderco and Sabrina Birsan
Biomedicines 2023, 11(4), 1016; https://doi.org/10.3390/biomedicines11041016
Available online: https://www.mdpi.com/2227-9059/11/4/1016

5. “The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection”
by Laura Mazzuti, Ombretta Turriziani and Ivano Mezzaroma
Biomedicines 2023, 11(1), 159; https://doi.org/10.3390/biomedicines11010159
Available online: https://www.mdpi.com/2227-9059/11/1/159

6. “The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19”
by Jide Tian and Daniel L. Kaufman
Biomedicines 2023, 11(2), 254; https://doi.org/10.3390/biomedicines11020254
Available online: https://www.mdpi.com/2227-9059/11/2/254

7. “Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives”
by Kristina Krpina, Semir Vranić, Krešimir Tomić, Miroslav Samaržija and Lara Batičić
Biomedicines 2023, 11(7), 1982; https://doi.org/10.3390/biomedicines11071982
Available online: https://www.mdpi.com/2227-9059/11/7/1982

8. “Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers”
by Satoshi Muto, Akio Enta, Yoshiyuki Maruya, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Masayuki Watanabe, Takuya Inoue et al.
Biomedicines 2023, 11(1), 190; https://doi.org/10.3390/biomedicines11010190
Available online: https://www.mdpi.com/2227-9059/11/1/190

9. “Training vs. Tolerance: The Yin/Yang of the Innate Immune System”
by Trim Lajqi, Natascha Köstlin-Gille, Reinhard Bauer, Sotirios G. Zarogiannis, Esra Lajqi, Valdrina Ajeti, Stefanie Dietz, Simon A. Kranig, Jessica Rühle, Ardian Demaj et al.
Biomedicines 2023, 11(3), 766; https://doi.org/10.3390/biomedicines11030766
Available online: https://www.mdpi.com/2227-9059/11/3/766

10. “Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders”
by Emanuela Senjor, Janko Kos and Milica Perišić Nanut
Biomedicines 2023, 11(2), 476; https://doi.org/10.3390/biomedicines11020476
Available online: https://www.mdpi.com/2227-9059/11/2/476

We would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field:

Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).

Biomedicines Editorial Office

25 November 2024
Biomedicines | Hot Papers in the “Cancer Biology and Oncology” Section

The “Cancer Biology and Oncology” Section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. The papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, provide a better understanding of the interrelations between cancer and metabolism as well as tumors and the microenvironment, and highlight the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such as involving CAR-T cells), the identification of novel therapeutic targets, and the evaluation of novel diagnosis and prognosis markers as well as the assessment of their impact on morphological, phenotypical, and molecular classifications.

1. “Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges
by Krisida Cerma, Federico Piacentini, Luca Moscetti, Monica Barbolini, Fabio Canino, Antonio Tornincasa, Federica Caggia, Sara Cerri, Alessia Molinaro, Massimo Dominici and Claudia Omarini
Biomedicines 2023, 11(1), 109; https://doi.org/10.3390/biomedicines11010109
Available online: https://www.mdpi.com/2227-9059/11/1/109

2. “Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer”
by Dzohara Murillo, Carmen Huergo, Borja Gallego, René Rodríguez and Juan Tornín
Biomedicines 2023, 11(1), 208; https://doi.org/10.3390/biomedicines11010208
Available online: https://www.mdpi.com/2227-9059/11/1/208

3. “Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors”
by Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano and Toshio Fukusato
Biomedicines 2023, 11(10), 2761; https://doi.org/10.3390/biomedicines11102761
Available online: https://www.mdpi.com/2227-9059/11/10/2761

4. “Oral Cavity Squamous Cell Carcinoma: An Update of the Pharmacological Treatment”
by Martina Imbesi Bellantoni, Giacomo Picciolo, Igor Pirrotta, Natasha Irrera, Mario Vaccaro, Federico Vaccaro, Francesco Squadrito and Giovanni Pallio
Biomedicines 2023, 11(4), 1112; https://doi.org/10.3390/biomedicines11041112
Available online: https://www.mdpi.com/2227-9059/11/4/1112

5. “Eph Receptors in Cancer”
by Sakshi Arora, Andrew M. Scott and Peter W. Janes
Biomedicines 2023, 11(2), 315; https://doi.org/10.3390/biomedicines11020315
Available online: https://www.mdpi.com/2227-9059/11/2/315

6. “Updates on Lymphovascular Invasion in Breast Cancer”
by Elisabetta Kuhn, Donatella Gambini, Luca Despini, Dario Asnaghi, Letterio Runza and Stefano Ferrero
Biomedicines 2023, 11(3), 968; https://doi.org/10.3390/biomedicines11030968
Available online: https://www.mdpi.com/2227-9059/11/3/968

7. “Targeted Therapy Development in Acute Myeloid Leukemia”
by Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, Anya Sondhi, Saanvi Bucha, Jacob Jahn, Yangbo Feng and Justin Taylor
Biomedicines 2023, 11(2), 641; https://doi.org/10.3390/biomedicines11020641
Available online: https://www.mdpi.com/2227-9059/11/2/641

8. “Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies”
by Gabriel Méndez-Valdés, Francisca Gómez-Hevia, José Lillo-Moya, Tommy González-Fernández, Joaquin Abelli, Antonia Cereceda-Cornejo, Maria Chiara Bragato, Luciano Saso and Ramón Rodrigo
Biomedicines 2023, 11(3), 718; https://doi.org/10.3390/biomedicines11030718
Available online: https://www.mdpi.com/2227-9059/11/3/718

9. “Mesenchymal Stem Cell-Derived Exosomes Modulate Angiogenesis in Gastric Cancer”
by Fawzy Akad, Veronica Mocanu, Sorin Nicolae Peiu, Viorel Scripcariu, Bogdan Filip, Daniel Timofte, Florin Zugun-Eloae , Magdalena Cuciureanu, Monica Hancianu, Teodor Oboroceanu et al.
Biomedicines 2023, 11(4), 1031; https://doi.org/10.3390/biomedicines11041031
Available online: https://www.mdpi.com/2227-9059/11/4/1031

10. “Combining Radiotherapy and Immunotherapy in Head and Neck Cancer”
by Juliana Runnels, Julie R. Bloom, Kristin Hsieh, Daniel R. Dickstein, Yuhao Shi, Brianna M. Jones, Eric J. Lehrer and Richard L. Bakst
Biomedicines 2023, 11(8), 2097; https://doi.org/10.3390/biomedicines11082097
Available online: https://www.mdpi.com/2227-9059/11/8/2097

We would like to take this opportunity to thank all the research groups that have submitted to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field:

Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).

Biomedicines Editorial Office

25 November 2024
Biomedicines | Hot Papers in the “Biomedical Engineering and Materials” Section

The “Biomedical Engineering and Materials” Section aims to publish contributions of studies on the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. It also covers biomedical engineering approaches as solutions to clinical practice.

1. “Modelling the Complexity of Human Skin In Vitro
by Elisabeth Hofmann, Anna Schwarz, Julia Fink, Lars-Peter Kamolz and Petra Kotzbeck
Biomedicines 2023, 11(3), 794; https://doi.org/10.3390/biomedicines11030794
Available online: https://www.mdpi.com/2227-9059/11/3/794

2. “Human In Vitro Skin Models for Wound Healing and Wound Healing Disorders
by Elisabeth Hofmann, Julia Fink, Anna-Lisa Pignet, Anna Schwarz, Marlies Schellnegger, Sebastian P. Nischwitz, Judith C. J. Holzer-Geissler, Lars-Peter Kamolz and Petra Kotzbeck
Biomedicines 2023, 11(4), 1056; https://doi.org/10.3390/biomedicines11041056
Available online: https://www.mdpi.com/2227-9059/11/4/1056

3. “Cellular and Molecular Processes in Wound Healing”
by Montserrat Fernández-Guarino, Maria Luisa Hernández-Bule and Stefano Bacci
Biomedicines 2023, 11(9), 2526; https://doi.org/10.3390/biomedicines11092526
Available online: https://www.mdpi.com/2227-9059/11/9/2526

4. “The Impact of Artificial Intelligence in the Odyssey of Rare Diseases”
by Anna Visibelli, Bianca Roncaglia, Ottavia Spiga and Annalisa Santucci
Biomedicines 2023, 11(3), 887; https://doi.org/10.3390/biomedicines11030887
Available online: https://www.mdpi.com/2227-9059/11/3/887

5. “Design and Prediction of Aptamers Assisted by In Silico Methods”
by Su Jin Lee, Junmin Cho, Byung-Hoon Lee, Donghwan Hwang and Jee-Woong Park
Biomedicines 2023, 11(2), 356; https://doi.org/10.3390/biomedicines11020356
Available online: https://www.mdpi.com/2227-9059/11/2/356

6. “Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future Perspectives”
by Matia Martucci, Rosellina Russo, Francesco Schimperna, Gabriella D’Apolito, Marco Panfili, Alessandro Grimaldi, Alessandro Perna, Andrea Maurizio Ferranti, Giuseppe Varcasia, Carolina Giordano et al.
Biomedicines 2023, 11(2), 364; https://doi.org/10.3390/biomedicines11020364
Available online: https://www.mdpi.com/2227-9059/11/2/364

7. “Scaffold Guided Bone Regeneration for the Treatment of Large Segmental Defects in Long Bones”
by Frank Schulze, Annemarie Lang, Janosch Schoon, Georgi I. Wassilew and Johannes Reichert
Biomedicines 2023, 11(2), 325; https://doi.org/10.3390/biomedicines11020325
Available online: https://www.mdpi.com/2227-9059/11/2/325

8. “Degradation and Failure Phenomena at the Dentin Bonding Interface”
by Lamia Sami Mokeem, Isadora Martini Garcia and Mary Anne Melo
Biomedicines 2023, 11(5), 1256; https://doi.org/10.3390/biomedicines11051256
Available online: https://www.mdpi.com/2227-9059/11/5/1256

9. “Artificial Intelligence in Acute Ischemic Stroke Subtypes According to Toast Classification: A Comprehensive Narrative Review”
by Giuseppe Miceli, Maria Grazia Basso, Giuliana Rizzo, Chiara Pintus, Elena Cocciola, Andrea Roberta Pennacchio and Antonino Tuttolomondo
Biomedicines 2023, 11(4), 1138; https://doi.org/10.3390/biomedicines11041138
Available online: https://www.mdpi.com/2227-9059/11/4/1138

10. “Conservative Treatment of Dental Non-Carious Cervical Lesions: A Scoping Review”
by Assunta Patano, Giuseppina Malcangi, Matteo De Santis, Roberta Morolla, Vito Settanni, Fabio Piras, Alessio Danilo Inchingolo, Antonio Mancini, Francesco Inchingolo, Gianna Dipalma et al.
Biomedicines 2023, 11(6), 1530; https://doi.org/10.3390/biomedicines11061530
Available online: https://www.mdpi.com/2227-9059/11/6/1530

We would like to take this opportunity to thank all the research groups that have submitted their papers to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.

Joining the Editorial Board:
If you are an active researcher in the field of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).

Biomedicines Editorial Office

15 November 2024
Prof. Dr. A. Douglas Kinghorn Appointed Chair of the 2024 Tu Youyou Award Committee


We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.

Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA

Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.

The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.

We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.

About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.

The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

5 November 2024
MDPI INSIGHTS: The CEO's Letter #17 - OA Week, Basel Open Day, Beijing Graphene Forum

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week: Forging the Future of Open Access through Global Reach and Collaboration

From 21 to 27 October, we celebrated International Open Access Week (OAW), highlighting the importance of making research accessible to everyone. This campaign reinforced our commitment to advancing open access (OA) and showcased how we are helping research communities worldwide adopt OA as their standard.

 

“OA publishing is now a cornerstone of global research”

Throughout the week, we featured MDPI’s efforts to support quality open research through blog posts on topics such as how Research Integrity Promotes OA Practices, our Preprints.org platform, and supporting societies with different OA models. These initiatives capture our commitment to making research more inclusive and accessible to all.

OA publishing is now a cornerstone of global research, with more researchers choosing OA over traditional paywalled models, and embracing new, community-driven models.

Benefits of Open Access and Open Research

  • Accelerated Discoveries: OA speeds up scientific progress by allowing immediate access to findings, enabling researchers to build on each other’s work faster.
  • Community-Led Innovation: Open research empowers communities to manage their own platforms, creating collaboration and shared knowledge.
  • Increased Visibility: OA broadens the reach of your research, leading to greater recognition, collaboration, and impact.
  • Cross-Disciplinary Connections: By removing financial and geographical barriers, OA unites diverse fields, sparking innovation across disciplines.

MDPI Singapore Celebrates Open Access Week

MDPI Singapore also hosted its first-ever OAW event at the Marina Bay Sands Convention Centre, bringing together academics, researchers, and students to discuss the future of open scholarship. Conversations focused on the potential of new publishing models, alternative funding strategies, and the importance of communicating research to wider audiences.

As OA evolves, MDPI remains a committed partner in advancing open science and creating a transparent, inclusive research environment. For a full recap of the week’s highlights and resources, visit our campaign page.

Impactful Research

MDPI Connection to Nobel-Winning Protein Research

David Baker, an American biochemist, and Demis Hassabis and John M. Jumper, two scientists from Google DeepMind, have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking advancements in better understanding the structure of proteins, the molecular engines of life’s processes.

One half of the prize was awarded to Professor David Baker from the University of Washington for his development of revolutionary protein design software enabling the creation of novel proteins for vaccines, nanomaterials, and sensors. Prof. Baker co-authored a 2016 paper in MDPI’s Toxins journal on protein-based therapeutics.

Meanwhile, DeepMind’s Demis Hassabis and John M. Jumper received recognition for AlphaFold, the AI model that predicts protein structures from amino acid sequences, fulfilling a long-held scientific dream.

“We congratulate this year’s Nobel laureates for their groundbreaking contributions to the study of life”

 Nobel Prize Laureates Entrust MDPI with Their Research

As at October 2024, 45 Nobel laureates had contributed to more than 115 articles across

35 MDPI journals. The privilege of hosting the research of such contributors, who significantly influence the open access movement, resonates deeply with our editorial teams.

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath, Tomas Lindahl, Thomas C. Südhof, Stanley B. Prusiner, Roger Kornberg, Robert F. Engle, Richard J. Roberts, Ōmura Satoshi, Kenneth J. Arrow, John B. Goodenough, Jennifer Doudna, Hamilton Othanel Smith, Eric R. Kandel, Carlo Rubbia, Bernard Feringa, Barry J. Marshall, Anthony J. Leggett, Andrew Victor Schally, and David Baker.

Notable MRNA Published in Cells

On 7 October 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

MicroRNAs are proving to be fundamentally important for how organisms develop and function. Some interesting papers about microRNA research are published in the MDPI journal Cells. I invite you browse through the notable papers related to microRNA research in Cells.

Inside MDPI

Basel Open Day

On 21 October, we held the Basel Open Day at our headquarters, welcoming a group of journal Editors-in-Chief (EiC) and Editorial Board Members (EBMs) for a full-day workshop. The event featured presentations and discussions on MDPI’s latest editorial updates, data integrity policies, society collaborations, and local market insights.

The following MDPI journals were represented during the visit: Physics, Journal of Personalized Medicine (JPM), Sci, Remote Sensing, Animals, Cells, Buildings, Histories, Sensors, and International Journal of Environmental Research and Public Health (IJERPH).

This was a great opportunity to showcase our new office space while gathering feedback from leading journal stakeholders. To get everyone on the same page, we took 60 minutes for round-table introductions, which helped set a collaborative tone and ground us in MDPI’s mission of disseminating open science.

“This was a great opportunity to gather feedback from leading journal stakeholders”

The general feedback from the day highlighted positive developments around our editorial and ethics policies, as well as areas for improvement, including flexibility regarding reviewer deadlines. There was a genuine appreciation and push for our ongoing efforts to share more about MDPI, including company updates and promoting high-quality research through our blog, announcements, and social media channels, which we have been growing and expanding.

Our Basel Open Day was a positive experience, bringing together key journal stakeholders and gathering insights to guide MDPI’s continued engagement with the academic community. We look forward to hosting future events of this kind and welcoming more scholars to our headquarters in Basel, Switzerland.

Coming Together for Science

ncRNA 2024 Conference in Basel

I am pleased to share that we held Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ICM 2024) in Basel, Switzerland this past 7–9 October.

The three-day event attracted just over 100 attendees, including two Chairs, 10 invited speakers and two keynotes from Prof. Mauro Giacca and Prof. Ling-Ling Chen. Of the presentations on site, there were 35 posters and 44 oral presentations.

The overall feedback was positive, with people enjoying the intimate event and the unique activities offered, including a guided tour around Basel’s Old Town (a must-see for anyone visiting the city) and a memorable conference dinner.

It was cool to see the winners of the 2024 Nobel Prize in Physiology or Medicine announced during the conference days. This was exciting for attendees, as the winners discovered a new class of RNA molecules (miRNAs). As one invited speaker put it, “It's exciting to be among fellows when something that important for the field is announced.”

“It's exciting to be among fellows when something that important for the field is announced”

Every attendee receives a conference survey, and I’m always pleased to see a high percentage of ‘Very Satisfied’ responses when asked about ‘treatment from conference personnel’. Kudos to our conference team for meeting our attendees’ needs. These events are a great opportunity for us to reach new audiences, as 92% of the respondents had never been to an MDPI conference, so I am thrilled to see us connecting with a new demographic of your researchers in the RNA field.

A special thank-you to our partnering societies The Epigenetics Society, The French Society of Genetics, LS2 / USGEB (Union of Swiss Societies for Experimental Biology), and The RNA Biology Group, as well as to our sponsors New England Biolabs and Arraystar for their support of the ncRNA 2024 conference. I am also pleased to report that we presented two awards, including the Best Presentation Award and two Best Poster Award, recognizing the contributions of our participants.

Upcoming In-Person Event

27–29 November 2024
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
Location: Barcelona, Spain

The discovery of new molecules, their properties, and actions to enhance human health and quality of life.

Find more upcoming MDPI events here.

Closing Thoughts

Beijing Graphene Forum 2024

I am pleased to share that we had a successful time at the Beijing Graphene Forum 2024, which drew around 1,000 attendees, including Konstantin Novoselov (2015 Nobel Prize in Physics) and other high-profile scholars in materials science and chemistry. It was a great opportunity to present MDPI on the big stage, with university presidents from institutions such as Peking University also in attendance.

I had the honour of awarding Prof. Zhongfan Liu, Chairman of the Chemical Science Committee, with a medal and presenting certificates to the members of the Chemical Science Committee; this is an important initiative to help expand MDPI’s journals and influence in China. These are highly respected scholars, and we enjoyed connecting with them over lunch as well.

“This is an important initiative to help expand MDPI’s journals and influence in China”

I also had the chance to speak about MDPI and open access, giving a five-minute speech during the opening ceremony and a 20-minute presentation at the close. MDPI hosted a sub-forum where both academic scholars and MDPI members shared insights, and we engaged with attendees at our MDPI booth.

This was a great opportunity to spotlight MDPI as the main publishing partner for the event, and I was proud to represent us on stage. We also met with scholars to discuss topics such as their publishing needs and institutional policies, open access, impact journals, and IOAP.

Stefan Tochev
Chief Executive Officer
MDPI AG

16 October 2024
MDPI's Newly Launched Journals in September 2024

Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.

We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.

We invite you to explore and learn more about these new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

15 October 2024
Meet Us at the Third ASBMB-BSC Symposium on the Interplay Between Epigenetic Regulation and Genome Integrity, 21–25 October 2024, Wuhan, China


The third ASBMB-BSC Symposium on the Interplay between Epigenetic Regulation and Genome Integrity will be held from 21 to 25 October 2024, in Wuhan, China. The conference is co-organized by the Biophysics Society of China (BSC) and the American Society for Biochemistry and Molecular Biology (ASBMB).

Topics include the following:

  • Epigenetic regulation of genome replication;
  • Dynamic epigenetic alterations maintaining genome stability;
  • Chromatin-based epigenetic inheritance;
  • The role of epigenetic alterations in cancer and aging.

The following MDPI journals will be represented at the conference:

  • CIMB;
  • Genes;
  • IJMS;
  • Biomedicines;
  • Epigenomes;
  • JDB.

If you are planning to attend this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at our booth #9 and answering any questions that you may have. For more information about the conference, please click the following link: https://www.bsc.org.cn/bsc-asbmb-epigenetics/.

4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)

On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.

It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!

Today’s youth are not just the leaders of tomorrow – they are already leading the change today.

Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”

MDPI Supports the Future Generation of Scientists

This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.

Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.

Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).

“We aim to address pressing global challenges”

MDPI and the SDGs

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.

During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.

Impactful Research

Presenting at the 1st International Conference of Environmental Medicine

In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.

The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.

The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.

MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.

“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”

The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.

Nobel Laureates’ Contributions to MDPI

As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.

Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.

Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.

MDPI’s Presence in Italy

Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.

We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.

Inside MDPI

Celebrating Peer Review Week, 23–27 September 2024

As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.

“We remain committed to enhancing the peer review process”

The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.

Peer Review Innovation and Technology at MDPI

Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.

Listening to MDPI’s Authors and Reviewers

We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.

We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:

Coming Together for Science

ICM 2024 – Advances in Material Innovation

I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.

This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.

We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.

A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.

Upcoming In-Person Event

7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland

ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.

Find more upcoming MDPI events here.

Closing Thoughts

Reflections from OASPA 2024 Conference in Lisbon (16–18 September)

Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.

“I believe that publishers have a lot to offer in terms of data and insights”

Main Themes from OASPA 2024

The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.

It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.

It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.

While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.

It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.

An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.

Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop